Lanopepden mesylate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLanopepden mesylate
Drug Alias NameLanopepdenum拉诺普登拉诺培登GSK-32212M6KFD07E +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionPeptide deformylase inhibitors
TargetsPeptide deformylase
Therapy Area/IndicationsSkin Diseases, BacterialBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsSkin Diseases, BacterialBacterial Infections

Other Information

ATC CodeN/A
Related LinksKEGG